TRG16, targeted by miR-765, inhibits breast cancer stem cell-like properties via regulating the NF-&#954;B pathway.

Chi, Feng; Jin, Xiaoming; Chen, Long; He, Guijin; Han, Sijia

TRG16, targeted by miR-765, inhibits breast cancer stem cell-like properties via regulating the NF-κB pathway.

Chi, Feng; Jin, Xiaoming; Chen, Long; He, Guijin; Han, Sijia.

Afiliação

Chi F; Department of Oncology, Shengjing Hospital of China Medical University, 39 Huaxiang Road, Shenyang, 110022, Liaoning, China.
Jin X; Department of Endocrinology, Northern Theater Air Force Hospital of the People's Liberation Army, Shenyang, Liaoning, China.
Chen L; Department of Breast Surgery, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, China.
He G; Department of Oncology, Shengjing Hospital of China Medical University, 39 Huaxiang Road, Shenyang, 110022, Liaoning, China.
Han S; Department of Oncology, Shengjing Hospital of China Medical University, 39 Huaxiang Road, Shenyang, 110022, Liaoning, China. stef2007@126.com.

Mol Cell Biochem ; 477(12): 2801-2816, 2022 Dec.

Article em En | MEDLINE | ID: mdl-35648115

Assuntos

Neoplasias da Mama; MicroRNAs; Humanos; Feminino; NF-kappa B/metabolismo; Regulação Neoplásica da Expressão Gênica; Neoplasias da Mama/patologia; Células-Tronco Neoplásicas/metabolismo; MicroRNAs/metabolismo; Linhagem Celular Tumoral

Palavras-chave

Breast cancer; Cancer stem cell-like properties; TRG16; The NF-κB pathway; miR-765

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / MicroRNAs Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Mol Cell Biochem Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google